Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Abbvie Inc (ABBV)

Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?

Revenue growth during what should be a disastrous patent cliff is encouraging.

CERE : 41.77 (-0.67%)
ABBV : 162.93 (-0.99%)
10 Stocks to Build a Dividend Portfolio With

All 10 of these stocks pay reliable and growing dividends.

GOOGL : 177.85 (+0.53%)
GOOG : 179.54 (+0.61%)
HD : 336.15 (-0.49%)
KO : 62.91 (+0.54%)
CAT : 359.07 (-1.01%)
CVX : 159.97 (-0.73%)
V : 275.95 (-0.93%)
NEE : 76.95 (+1.42%)
ABBV : 162.93 (-0.99%)
PLD : 110.60 (-1.29%)
MSFT : 429.04 (+0.87%)
3 Cheapest Dividend Kings To Buy Today

This article covers three buy-rated companies that've increased their dividends for 50+ consecutive years.

FRT : 101.29 (+0.28%)
ABBV : 162.93 (-0.99%)
TGT : 155.78 (-0.59%)
3 Magnificent Stocks That Are Passive Income Machines

These three companies have track records that should please investors.

LLY : 803.17 (+2.55%)
ABBV : 162.93 (-0.99%)
NVS : 102.84 (unch)
What Is the Dividend Payout for AbbVie Stock?

The pharmaceutical company isn't just a quality healthcare holding. It's a compelling income investment as well.

ABBV : 162.93 (-0.99%)
Forget Weight-Loss Drugs, Here's the Next Breakthrough Pharma Stock

There is another segment of the pharma industry that is as hot as weight-loss drugs: antibody-drug conjugates, or ADCs. These treatments will, in the near future, replace conventional chemotherapy, thanks...

PFE : 28.56 (+0.11%)
ABBV : 162.93 (-0.99%)
JNJ : 151.24 (-0.02%)
RHHBY : 32.3300 (-1.34%)
GMAB : 29.15 (-1.82%)
AZN : 79.18 (+2.68%)
DSNKY : 35.0800 (-0.90%)
MRK : 130.76 (-0.18%)
LLY : 803.17 (+2.55%)
NVO : 135.16 (+1.69%)
5 Standout Healthcare Dividend Stocks to Consider Now

Amid healthcare’s enduring importance and increasing demand for its products and services, here are five dividend-paying healthcare stocks to consider now.

JNJ : 151.24 (-0.02%)
MRK : 130.76 (-0.18%)
ABBV : 162.93 (-0.99%)
PFE : 28.56 (+0.11%)
MDT : 85.17 (+0.78%)
Earn $1000 Every Month From These 3 Stocks

All 3 companies pay growing dividends.

PFE : 28.56 (+0.11%)
MO : 46.33 (+0.94%)
ABBV : 162.93 (-0.99%)
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.

These pharmaceutical companies are top-notch dividend growth stocks for the future.

NVO : 135.16 (+1.69%)
LLY : 803.17 (+2.55%)
ABBV : 162.93 (-0.99%)
3 Rock-Solid Dividend Stocks That Are Ideal for Retirees

These are low-risk stocks with high yields.

ABBV : 162.93 (-0.99%)
T : 17.27 (-1.43%)
XOM : 117.85 (-0.69%)

Barchart Exclusives

Should You Follow Warren Buffett Into This Dividend Stock?
Chubb is an insurance stock, and the newest addition to Berkshire Hathaway's portfolio, which looks positioned to deliver outsized gains to shareholders in 2024 and beyond. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar